Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | GSK3A | P49840 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 2/20 | 0.38 |
| ▸ | PRSS12 | P56730 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CETP | P11597 | 1/20 | 0.36 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.36 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.36 |
| ▸ | XDH | P47989 | 1/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6833960 | 0.93 | MCL1 (0.43) | MCL1HIF1AMAPTGSK3AGSK3B | |
| SCHEMBL6834160 | 0.90 | HIF1A (0.39) | HIF1AMAPTGSK3AGSK3BALB | |
| SCHEMBL6833104 | 0.89 | HIF1A (0.49) | HIF1AALBPRSS12SERPINE1XDH | |
| SCHEMBL6830592 | 0.87 | EPHX2 (0.43) | HIF1AMAPTALBPRSS12CETP | |
| SCHEMBL6818765 | 0.86 | ALB (0.37) | HIF1AMAPTGSK3AGSK3BALB | |
| SCHEMBL6818998 | 0.86 | HIF1A (0.39) | HIF1AMAPTGSK3AGSK3BALB | |
| SCHEMBL6817639 | 0.85 | ALB (0.36) | HIF1AMAPTGSK3AGSK3BALB | |
| SCHEMBL6821275 | 0.84 | HIF1A (0.38) | MCL1HIF1AMAPTGSK3AGSK3B | |
| Sulfuric Acid SCHEMBL6833366 | 0.84 | EPHX2 (0.41) | HIF1AMAPTALBPRSS12CETP | |
| SCHEMBL6818903 | 0.84 | PRSS12 (0.40) | MCL1MAPTGSK3AGSK3BALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | MCL1 2086/4885HIF1A 220/4885MAPT 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.